Skip to main content

Animations

MJFF Publications

6231 - 6240 of 8673 Results
Title
Year
  • Year
  • 2024
  • 2020
  • 2023
  • 2024
  • 2017
  • 2022
  • 2020
  • 2024
  • 2018
  • 2020
  • Summary Details
    OPEN
    Title: The combined effect of lifestyle factors and polygenic scores on age at onset in Parkinson’s disease
    Journal Name: Scientific Reports
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1038/s41598-024-65640-x
    Citation Count: 4
  • Summary Details
    OPEN
    Title: White Matter Hyperintensities Related to Parkinson's Disease Executive Function
    Journal Name: Movement Disorders Clinical Practice
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc-nd
    DOI - Digital Object Identifier: 10.1002/mdc3.12956
    Citation Count: 47
  • Summary Details
    OPEN
    Title: The Michael J. Fox Foundation's quest for a cure for Parkinson's disease: an interview with Nicole Polinski
    Journal Name: Disease Models & Mechanisms
    Publisher: The Company of Biologists
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1242/dmm.050605
    Citation Count: 0
  • Summary Details
    RESTRICTED
    Title: Global Perspectives on Returning Genetic Research Results in Parkinson Disease
    Journal Name: Neurology Genetics
    Publisher: Ovid Technologies (Wolters Kluwer Health)
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1212/nxg.0000000000200213
    Citation Count: 3
  • Summary Details
    OPEN
    Title: Investigating the genetic architecture of dementia with Lewy bodies: a two-stage genome-wide association study
    Journal Name: The Lancet Neurology
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License: publisher-specific-oa
    DOI - Digital Object Identifier: 10.1016/s1474-4422(17)30400-3
    Citation Count: 240
  • Summary Details
    OPEN
    Title: Functional Analyses of Two Novel LRRK2 Pathogenic Variants in Familial Parkinson′s Disease
    Journal Name: Movement Disorders
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1002/mds.29124
    Citation Count: 7
  • Summary Details
    RESTRICTED
    Title: PPMI 2.O New Science/New Cohorts - Transforming PPMI (2490)
    Journal Name: Neurology
    Publisher: Ovid Technologies (Wolters Kluwer Health)
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1212/wnl.94.15_supplement.2490
    Best OA location URL:
    Citation Count: 7
  • Summary Details
    RESTRICTED
    Title: Blood-Based Nanoparticle-Enhanced Quaking-Induced Conversion (Nano-QuIC): Inhibitor-Resistant Detection of Seeding Activity in Patients Diagnosed with Parkinson’s Disease
    Journal Name: Nano Letters
    Publisher: American Chemical Society (ACS)
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1021/acs.nanolett.4c03768
    Best OA location URL:
    Citation Count: 4
  • Summary Details
    OPEN
    Title: Guanabenz promotes neuronal survival via enhancement of ATF4 and parkin expression in models of Parkinson disease
    Journal Name: Experimental Neurology
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1016/j.expneurol.2018.01.015
    Best OA location URL:
    Citation Count: 39
  • Summary Details
    OPEN
    Title: Forecasts for the Attainment of Major Research Milestones in Parkinson’s Disease
    Journal Name: Journal of Parkinson's Disease
    Publisher: SAGE Publications
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.3233/jpd-201933
    Citation Count: 4
We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.